Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.

Key facts

Study ID

NCT03092882

Run by

Evidation Health

People needed

607

Starts

2017-03-03

Expected to finish

2018-02-07

Last updated by the study team

2019-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Humana Medicare Advantage member
• Type 2 diabetes diagnosis
• HbA1c levels ≥ 8.0% verified by lab test

You may not qualify if…

• Has any of the following conditions: cancer, chronic heart failure, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage renal disease, peripheral vascular disease
• Not fluent in English
• Humana membership is part of a Full or Global risk arrangement
• Enrolled in Humana at Home Care Management

Where it is running

• Evidation Health — San Mateo, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.